797
Views
4
CrossRef citations to date
0
Altmetric
Review

Comparing the efficacy and safety of salmeterol/fluticasone pMDI versus its mono-components, other LABA/ICS pMDIs and salmeterol/fluticasone Diskus in patients with asthma

, , &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Abdelwahab Omri. (2015) Pulmonary drug and vaccine delivery: therapeutic significance and major challenges. Expert Opinion on Drug Delivery 12:6, pages 853-855.
Read now

Articles from other publishers (3)

Scott HaughieRichard AllanNolan WoodJon Ward. (2020) Equivalent Systemic Exposure to Fluticasone Propionate/Salmeterol Following Single Inhaled Doses from Advair Diskus and Wixela Inhub: Results of Three Pharmacokinetic Bioequivalence Studies. Journal of Aerosol Medicine and Pulmonary Drug Delivery 33:1, pages 34-42.
Crossref
Qian Zhong, Olivia M. Merkel, Joshua J. Reineke & Sandro R. P. da Rocha. (2016) Effect of the Route of Administration and PEGylation of Poly(amidoamine) Dendrimers on Their Systemic and Lung Cellular Biodistribution. Molecular Pharmaceutics 13:6, pages 1866-1878.
Crossref
Masayuki Hojo, Toshihiro Shirai, Junko Hirashima, Motoyasu Iikura & Haruhito Sugiyama. (2016) Comparison of the clinical effects of combined salmeterol/fluticasone delivered by dry powder or pressurized metered dose inhaler. Pulmonary Pharmacology & Therapeutics 37, pages 43-48.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.